nitric oxide system raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-16 and is reviewed periodically as new material appears.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
| Property | Value | Notes |
|---|---|---|
| Origin | Fragment of a protein found in human gastric juice | Sequence corresponds to a fifteen-residue portion of the parent protein |
| Sequence | GEPPPGKPADDAGLV | Single linear chain, fifteen amino acids |
| Reported molecular weight | About 1419 daltons | Value quoted consistently in supplier and review literature |
| Regulatory status | Not an approved human medicine in the US or EU | Handled and sold as a research chemical |
| Sports status | Listed as prohibited | Falls under non-approved-substance categories in anti-doping codes |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Opposing Force received mainly positive reviews, holding a score of 85.45% on the review aggregator site GameRankings. In the United States, the game sold 108,008 copies by the end of 1999. Although figures for sales on Steam have not been released, Opposing Force eventually sold over 1.1 million copies at retail. Computer and Video Games reviewer Kim Randell noted that "Gearbox has obviously gone to great pains to provide a similar experience to the original". Praise was also given to the multiplayer; Randell stated that the new additions for multiplayer made it the area of Opposing Force that "really shines". Randell closed the review by concluding that Opposing Force is "an awesome achievement". Erik Wolpaw, writing for GameSpot, noted that as most expansion packs were mediocre, "it's appropriate that Gearbox Software's Opposing Force, the official expansion for the genre-redefining Half-Life, in turn sets a new standard of quality for future action-game mission packs". Wolpaw praised the design of the single-player campaign, commenting that "you can sense the designers' enthusiasm as one memorable scene unfolds after another, and it compels you to keep playing". Although criticizing some elements of the artificial intelligence and describing some of the new models as "merely window dressing", the review concluded that Opposing Force was an "impassioned application of creative design".
== The use of "Intracrine" == As described above, intracrine signaling, also called intracrine action, is a process in which a cell produces a hormone that acts within the same cell that synthesized it. However, the term "intracrines" can be used more broadly to refer to all hormones that act on receptors within the cell, regardless of whether they act on their cell of origin. This means that while some intracrines function in a strictly intracrine manner, others may be secreted to influence neighboring cells. In such cases, an intracrine can function in a paracrine manner while still exerting its effects within the original cell through intracellular signaling.
Agnolín, Bogan & Lucero (2026) consider Balaena pampaea, Notiocetus romerianus and N. platensis to be nomina dubia, interpreting the fossil material of N. platensis as remains of an indeterminate baleen whale, and interpreting fossils of B. pampaea and N. romerianus as remains of an indeterminate balaenid. Lambert et al. (2026) report shark feeding traces on bones of cetacean specimens from the Pliocene Kattendijk Formation (Belgium), including evidence of a bluntnose sixgill shark feeding on a right whale Balaenella brachyrhynus and evidence of Carcharodon plicatilis feeding on a member of the genus Casatia. López-Galán, Ferrón & Botella (2026) study ecomorphological variation of extant and extinct filter-feeding cetaceans, pachycormiform fishes and selachians, interpreting members of the three groups as repeatedly converging toward analogous functional designs, but also interpreting their convergent evolution as influenced by lineage-specific constraints.
== Clinical significance == Myositis may cause thickening of the muscle fascicles. This may be detected with ultrasound scans. Muscle fascicle structure is a useful diagnostic tool for dermatomyositis. Myocytes towards the edges of the muscle fascicle are typically narrower, while those at the centre of the muscle fascicle are a normal thickness. Muscle fascicles may be involved in myokymia, although commonly only individual myocytes are involved.
=== Laboratory tests === Serum creatine kinase (CK) is the most commonly used biomarker of muscle injury, and is often supplemented by aldolase, lactate dehydrogenase and the aminotransferases. However, elevated CK is not specific to myopathy, and isolated raised CK ("hyperCKemia") has a poor diagnostic yield on its own. Where an idiopathic inflammatory myopathy is suspected, testing for myositis-specific autoantibodies (MSAs) is recommended, ideally before starting immunosuppression, as these antibodies define distinct clinical subtypes and patterns of organ involvement.
Sources: en.wikipedia.org
During this period, Aden became important for British military and commercial purposes in the region, as well as a base for the Royal Navy and the Royal Air Force. The colony's surrounding hinterland, was governed separately as the Aden Protectorate. By the early 1960s, widespread dissatisfaction with British rule led to the Aden Emergency, a violent uprising against colonial authorities. In 1963, Aden Colony was reconstituted as the State of Aden within the newly created Federation of South Arabia in an attempt to grant limited self-governance, but the unrest continued. The British withdrew in 1967, and the colony was succeeded by the People's Republic of Southern Yemen, marking the end of British control after 128 years of rule.
In medieval Europe, early Christian monasteries adopted Roman aquacultural practices. Aquaculture spread because people away from coasts and big rivers were otherwise dependent on fish which required salting in order to be preserved. Fish was an important food source in medieval Europe, when in average 150 days per year were days of fasting and abstinence, and meat was prohibited. Improvements in transportation during the 19th century made fresh fish easily available and inexpensive, even in inland areas, rendering aquaculture less popular. The 15th-century fishponds of the Trebon Basin in the present-day Czech Republic are maintained as a tentative UNESCO World Heritage Site. Samoans practised "a traditional form of giant clam ranching". Hawaiians constructed oceanic fish ponds. A remarkable example is the "Menehune" fishpond dating from at least 1,000 years ago, at Alekoko. Legend records its construction by the mythical Menehune dwarf-people. In the first half of the 18th century, German Stephan Ludwig Jacobi experimented with external fertilization of brown trout and salmon. He wrote an article "Von der künstlichen Erzeugung der Forellen und Lachse" (On the Artificial Production of Trout and Salmon) summarizing his findings, and earning him a reputation as the founder of artificial fish-rearing. By the latter decades of the 18th century, oyster-farming had begun in estuaries along the Atlantic Coast of North America. The word "aquaculture" appeared in an 1855 newspaper article in reference to the harvesting of ice.
The Napoleonic wars also played a key role in the independence of the Latin American colonies from Spain and Portugal. The conflict weakened the authority and military power of Spain, especially after the Battle of Trafalgar. There were many uprisings in Spanish America, leading to the wars of independence. In Portuguese America, Brazil experienced greater autonomy as it now served as seat of the Portuguese Empire and ascended politically to the status of Kingdom. These events also contributed to the Portuguese Liberal Revolution in 1820 and the Independence of Brazil in 1822. The century of relative transatlantic peace, after the Congress of Vienna, enabled the "greatest intercontinental migration in human history" beginning with "a big spurt of immigration after the release of the dam erected by the Napoleonic Wars." Immigration inflows relative to the US population rose to record levels (peaking at 1.6 percent in 1850–1851), as 30 million Europeans relocated to the United States between 1815 and 1914. Another concept emerged from the Congress of Vienna—that of a unified Europe. After his defeat, Napoleon deplored the fact that his dream of a free and peaceful "European association" remained unaccomplished. Such a European association would share the same principles of government, system of measurement, currency and Civil Code. One-and-a-half centuries later, and after two world wars several of these ideals re-emerged in the form of the European Union.
The oxidative burst is a defense mechanism in which neutrophils produce and release reactive oxidative species in the vicinity of bacteria or fungi to destroy the foreign cells. Glutathione Reductase deficient neutrophils were shown to produce a more transient oxidative burst in response to bacteria than neutrophils that express GR at ordinary levels. The mechanism of Glutathione Reductase in sustaining the oxidative burst is still unknown.
Ubiquitin is a small protein that exists in all eukaryotic cells. It performs its myriad functions through conjugation to a large range of target proteins. A variety of different modifications can occur. The ubiquitin protein itself consists of 76 amino acids and has a molecular mass of about 8.6 kDa. Key features include its C-terminal tail and the 7 lysine residues. It is highly conserved throughout eukaryote evolution; human and yeast ubiquitin share 96% sequence identity. Moreover, human and yeast ubiquitin share two conserved salt bridges, K11–E34 and K27–D52, which are critical for protein stability and function.
Sources: en.wikipedia.org
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.
The peptide was named after a protein fraction found in human gastric juice, and the shorter form was called body protection compound. That phrase was shortened to the abbreviation BPC. The number 157 refers to a laboratory designation used in the original isolation work.
Its sequence corresponds to a segment of a protein present in gastric secretions, but the material supplied for research is made synthetically. No commercial product is purified from human or animal tissue. The synthetic route is used because it gives a defined chain length and a reproducible sequence.
Reversed-phase liquid chromatography with ultraviolet detection gives a purity estimate, while mass spectrometry confirms molecular mass and flags modifications. Amino acid analysis can add compositional confirmation. Results are most meaningful when a validated reference standard is run alongside the sample.